Harnessing AI for Healthcare: A Multi-Faceted Approach by AstraZeneca at Cypher 2023

At Cypher 2023, a panel of experts from AstraZeneca delved into the transformative role of Artificial Intelligence (AI) in the healthcare sector. The panel consisted of Govind Rajith Cheramkalam, Director – Commercial Reporting and Analytics, Gopinath PR, Data Science Incubation Lead, Shobana Muthukrishnan, Senior Manager – GBS Advanced Analytics Solutions, and Dinesh Ramu, Brand Analytics Lead.

The Pharma Industry and AI

Govind Rajith Cheramkalam opened the discussion by highlighting the vast scope of AstraZeneca, a leading bio-pharmaceutical company. He emphasized that the company is not just about drug discovery but also about leveraging data science within the organization. He also touched upon the life cycle of a drug, which can take up to 20 years from molecule to medicine.

The Role of Analytics

Dinesh Ramu explained how analytics plays a crucial role in the pharmaceutical industry. From identifying the right professionals for drug discovery to targeting the right doctors for drug distribution, analytics is at the heart of these operations. He also mentioned that the data is analyzed to understand sales patterns, demographic distributions, and competitive landscapes.

Generative AI in Healthcare

Gopinath PR focused on the role of generative AI in healthcare. He discussed how large language models (LLMs) can be used to summarize vast amounts of data, making it easier for business users to gain insights. He also touched upon the use of retrieval-augmented generation (RAG) architecture to ensure data privacy and reduce hallucination in AI models.